Stuart Mudge
Chief Operating OfficerDr. Stuart Mudge is Chief Operating Officer of Ceryvyn Therapeutics Limited (formerly known as Opthea Limited) from 2026. He has been Vice President of Scientific Affairs at Mayne Pharma Group Limited since January 2015 and also served as its Vice President of Research and Development and Regulatory and Clinical Affairs Director. Dr. Mudge has more than 11 years of experience in regulatory affairs across European, USA and australasian markets. His background includes product development planning, global regulatory submission strategy, direct interactions with the major international regulatory authorities, dossier preparation and submission and post-approval lifecycle management. Previously, he was the General Manager and Senior Director at Voisin Consulting australia pty ltd.
Positions
- Company NameCeryvyn Therapeutics LimitedStock CodeCYVNYPositionChief Operating OfficerColleagues
- JMJeremy Max LevinExecutive Chair & CEO
- HGHamish GeorgeCFO & Joint Company Secretary
- MGMichael GeromettaChief Technology Officer
- RWRebbecca WilcoxSenior VP of Preclinical and Translational Science
- LBLawrence B. GozlanIndependent Non-Executive Director
- KEKatherine Ellen-Danielle ConnellIndependent Non-Executive Director
- FXFrancis X. MccormackCo-Chair of Scientific Advisory Board
- DYDeborah YatesCo-Chair of Scientific Advisory Board
